17
Funding Innovation Through Pre-commercial Procurement IMSTA Conference March 2015 Dr Anne Blackwood CEO, Health Enterprise East

Anne Blackwood

Embed Size (px)

Citation preview

Page 1: Anne Blackwood

Funding Innovation Through

Pre-commercial Procurement

IMSTA Conference

March 2015

Dr Anne Blackwood

CEO, Health Enterprise East

Page 2: Anne Blackwood

Health Enterprise East: A Leading NHS Innovation

Hub

NHS Services

Professional IP Services for NHS Trusts

From idea to prototype for testing

Protection & commercialisation of IP

34 NHS organisations are members

Not for profit CLG structure

Part of national network of ‘NHS

Innovation Hubs’

Serves the IP needs of NHS Trusts

MedTech Services

Clinical access & analysis of output for business

Workshops, focus groups & interviews

Observational research

Care pathway analysis

Need translation

Product feedback and validation

Serves SME’s needs in access to NHS

Page 3: Anne Blackwood

Over 1300 NHS innovation disclosures assessed to

date

Over 120 commercial licenses granted last 5 years

3 spin out companies completed, with 8 further

potential opportunities in the pipeline

Annual Innovation Competitions run to celebrate NHS

innovation

35 technology projects in current pipeline

Supporting NHS Innovation

Page 4: Anne Blackwood

Health Innovation Scout Network

Innovation Scouts

Identify, assess and bring forward new innovations from their

NHS Organisation to HEE for development

Raise awareness of innovation throughout their organisation

Promote adoption and diffusion of new ideas and best

practice

Innovation Scout Network

Established by HEE in 2008 with funding from BIS

Provided Innovation Scout training to over 100 NHS staff

Work with 50 active Innovation Scouts from our NHS

member organisations

Supported by Eastern Academic Health Science Network

Page 5: Anne Blackwood

The NHS in Numbers

£100bn

NHS England

Budget 2014/15

£9.8bn

Annual cost to

NHS of

diabetes

1.7 million

people employed

by the NHS

£30bn

Projected NHS

‘funding gap’ by

2020

Page 6: Anne Blackwood

Medicine 2020 and beyond - drivers for change

Page 7: Anne Blackwood

Medicine 2020 and beyond - drivers for change

Innovative models of care

Expert patient/point-of-care diagnostics

More creative use of ICT (monitoring, telemedicine, integrated care)

New treatments for chronic disease (eg diabetes, cardiac disease, stroke,

lung disease, cancer)

Ethical issues e.g. care of the elderly, end of life care

Innovation – new drugs/diagnostics/technologies/health delivery

systems

More individualised prevention and treatment, stratified medicine

Ambulatory care

Page 8: Anne Blackwood

SBRI Healthcare: NHS England initiative to

identify unmet needs within the health service and

fund companies to develop solutions

www.sbrihealthcare.co.uk

Page 9: Anne Blackwood

SBRI is a pan-government, structured process enabling the

Public Sector to engage with Innovative suppliers:

Helping the Public Sector address challenges

• Using innovation to achieve a step change

Accelerating technology commercialisation

• Providing a route to market

Support and the development of Innovative companies

• Providing a lead customer/R&D partner

• Providing funding and credibility for fund raising

Page 10: Anne Blackwood

SBRI Key features

100% funded R&D

Operate under procurement rules rather than state aid rules

• Deliverable based rather than hours worked or costs

incurred

Contract with Prime Supplier

• Who may choose to sub contract but remains accountable

IP rests with Supplier

• Certain usage rights with Public Sector – companies

encouraged to exploit IP

• Light touch Reporting & payments quarterly & up front

Page 11: Anne Blackwood
Page 12: Anne Blackwood

SBRI Healthcare:

A Strong Established Programme

7m

patients

helped

24 clinically led

challenges during annual

cycle of 2 challenges

Total Possible Annual Savings, £434m**

** This includes double-counting of some savings but excludes other

significant possible gains

13

8 c

on

trac

ts

£35m invested

since 2012

93 feasibility contracts (phase 1)

37 development contracts (phase 2)

8 implementation contracts (phase 3)

150 jobs, 31 patents/TMs, £10m+

VC/investor funds leveraged

£1.5bn in

efficiency

savings*

• Min. estimate over 10 year period, Office for Health Economics & internal

figures, Summer 2014

Page 13: Anne Blackwood

SBRI Case Studies

Page 14: Anne Blackwood

The Noctura 400 is based on Organic Light Emitting

Diode (OLED) technology which offers a patient

centric, non invasive home based monitoring

treatment for patients with DR and age-related

macular degeneration (AMD).

Light therapy sleep mask could prevent blindness and

save the NHS £1bn a year.

The company are currently engaged in a multi-centre

Phase III trial of the technology at Moorfields Hospital,

London.

The company have increased 5 fold, have all their

manufacturing in the UK and are based at the National

Printable Electronics Centre in Sedgefield.

Case Study: Polyphotonix

SME PolyPhotonix has worked with the Liverpool University Hospitals Ophthalmology team to

create a light therapy sleep mask which is CE certified for the treatment of diabetic

retinopathy (DR).

Page 15: Anne Blackwood

Case Study: Fuel 3D Technologies

Oxford University Spin out Company, Fuel 3D Technologies has devised a novel 3D

camera which allows for improved monitoring and clinical intervention of chronic wounds in

clinics, hospitals and in patient homes.

The Fuel 3D wound measurement system, which was

launched in the UK in December 2011 and is already

being used in 25 NHS hospitals and primary care

settings, allows community nurses to monitor the

wounds while having the back-up of hospital-based

experts

Images can be evaluated without the need for patients

to visit outpatients – increasing effectiveness and

reducing costs. The technology allows wounds to be

assessed by volume giving a more accurate picture of

wound healing

Page 16: Anne Blackwood

Case Study: uMotif

Clinicians are provided with simple, relevant portals to

view, manage and stratify their patient groups, improving

the process of shared decision making

An initial trial has been completed in Parkinson’s Disease

where the simple, engaging user interface achieve 70%

daily use rates and a statistically significant increase in

patient adherence to medication

uMotif commenced a multi-centre trial in 7 major NHS

centres across the UK in January 2014

London Based uMotif have created mobile and web apps that combine patient-led data

inputs and a range of engaging content to help patients better self-manage their health

Page 17: Anne Blackwood

Health Enterprise East

SBRI Healthcare management partner

1010 Cambourne Business Park,

Cambourne,

Cambridge, CB23 6DP,

United Kingdom.

Tel. +44 (0)1223 597813

[email protected]

www.hee.co.uk

Contact Information

Anne Blackwood

CEO